Panugan, Rhynie Mae -.
HRN: 19-03-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/23/2022
04/29/2022
IVT
250mg
Q6
Bibasal Crackles
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes